No payment accepted from any clinic or pharmacy listed. No referral fees, no coupon codes, no partnerships.How we make money
← GLP Success
Comparison

Belle vs Ivim Health

Independent, side-by-side. Same methodology, same sourcing standard, no payment accepted from either. Prices are observed market pricing (snapshot 2026-07-20); receipts are computed from sourced records.

BelleIvim Health
VerdictProfile in progressProfile in progress
Tirzepatide pricefrom $199/mo (6-mo prepay)from $548/mo (monthly plan)
Semaglutide pricefrom $119/mo (6-mo prepay)from $299/mo (monthly plan)
Pharmacy receiptNames its pharmacy (BPI Labs, Hallandale Pharmacy +5) — BPI Labs is an FDA-registered 503B outsourcing facility (federal cGMP oversight); Hallandale Pharmacy, Boudreaux's New Drug Store +2 state-verified by us in up to 15 states. Pick your state to check yours.Fills through Empower, Tailor Made per market data — Empower is an FDA-registered 503B outsourcing facility (federal cGMP oversight). Pick your state to check the rest.
Care receiptIn-house clinicians; check-ins and coaching on record.In-house clinicians; check-ins and coaching on record.
Review integrityClean review record — 16% unprompted on 1,116 reviews, within our 40% threshold.Review-integrity flag — 66% of its Trustpilot reviews are unprompted "organic" posts, past our 40% gaming threshold.
Company addressLists a real-looking operating address on its own site.Lists a real-looking operating address on its own site.
PharmacyIn reviewIn review
Clinical supportIn reviewIn review
Patient supportIn reviewIn review
ValueIn reviewIn review
Ships to50 statesIn review
Pharmacy modelDiscloses its compounding pharmacies per product on its own treatments page (joinbelle.com/treatments, accessed 2026-07-15): BPI, Hallandale, Boudreaux, and VialsRx for GLP-1 products (plus Olympia for NAD+, not yet profiled here). The page also states "Belle is not the compounding pharmacy or manufacturer."Telehealth platform that does not compound medication itself; a licensed provider evaluates the patient and prescribes compounded semaglutide or tirzepatide, which is then filled by external state-licensed compounding pharmacies. Ivim describes these as FDA-regulated, state-licensed compounding pharmacies and references Certificate of Analysis, sterility, potency, pH, and endotoxicity testing, but does not publicly name them. The FDA warning letter (02/20/2026) found that Ivim is not the compounder of the products despite product labels bearing the Ivim name.
Red flags on file01

Full profiles: Belle · Ivim Health
State-aware license reads: the tirzepatide price board →